These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 35433888)
1. Screening of Lipid Metabolism-Related Gene Diagnostic Signature for Patients With Dilated Cardiomyopathy. Xu M; Guo YY; Li D; Cen XF; Qiu HL; Ma YL; Huang SH; Tang QZ Front Cardiovasc Med; 2022; 9():853468. PubMed ID: 35433888 [TBL] [Abstract][Full Text] [Related]
2. Identification of Target Genes and Transcription Factors in Mice with LMNA-Related Dilated Cardiomyopathy by Integrated Bioinformatic Analyses. Zhou H; Tan L; Lu T; Xu K; Li C; Liu Z; Peng H; Shi R; Zhang G Med Sci Monit; 2020 Jun; 26():e924576. PubMed ID: 32581210 [TBL] [Abstract][Full Text] [Related]
3. Integrated microarray analysis to identify potential biomarkers and therapeutic targets in dilated cardiomyopathy. Zhang H; Huo J; Jiang W; Shan Q Mol Med Rep; 2020 Aug; 22(2):915-925. PubMed ID: 32626989 [TBL] [Abstract][Full Text] [Related]
4. Integrated Bioinformatics Analysis Reveals the Aberrantly Methylated Differentially Expressed Genes in Dilated Cardiomyopathy. Li N; Wang J; Wang X; Zha L Int J Med Sci; 2024; 21(9):1769-1782. PubMed ID: 39006834 [TBL] [Abstract][Full Text] [Related]
5. Identification and Verification of Feature Biomarkers Associated With Immune Cells in Dilated Cardiomyopathy by Bioinformatics Analysis. Zhu T; Wang M; Quan J; Du Z; Li Q; Xie Y; Lin M; Xu C; Xie Y Front Genet; 2022; 13():874544. PubMed ID: 35646094 [No Abstract] [Full Text] [Related]
6. Exploring the Communal Pathogenesis, Ferroptosis Mechanism, and Potential Therapeutic Targets of Dilated Cardiomyopathy and Hypertrophic Cardiomyopathy Wang Z; Xia Q; Su W; Cao M; Sun Y; Zhang M; Chen W; Jiang T Front Cardiovasc Med; 2022; 9():824756. PubMed ID: 35282347 [TBL] [Abstract][Full Text] [Related]
7. An Robust Rank Aggregation and Least Absolute Shrinkage and Selection Operator Analysis of Novel Gene Signatures in Dilated Cardiomyopathy. Ma X; Mo C; Huang L; Cao P; Shen L; Gui C Front Cardiovasc Med; 2021; 8():747803. PubMed ID: 34970603 [No Abstract] [Full Text] [Related]
8. The Potential of Metabolism-Related Gene OGDHL as a Biomarker for Myocardial Remodeling in Dilated Cardiomyopathy. Tang Y; Zhu Y; Lu Y; Yang H; Yang H; Li L; Liu C; Du Y; Yuan J Front Cardiovasc Med; 2022; 9():741920. PubMed ID: 35463769 [TBL] [Abstract][Full Text] [Related]
9. Bioinformatics identifies key genes and potential drugs for energy metabolism disorders in heart failure with dilated cardiomyopathy. Wang H; Cai P; Yu X; Li S; Zhu W; Liu Y; Wang D Front Pharmacol; 2024; 15():1367848. PubMed ID: 38510644 [No Abstract] [Full Text] [Related]
10. Identification of the distinctive role of DPT in dilated cardiomyopathy: a study based on bulk and single-cell transcriptomic analysis. Lu Y; Wu Q; Liao J; Zhang S; Lu K; Yang S; Wu Y; Dong Q; Yuan J; Zhao N; Du Y Ann Transl Med; 2021 Sep; 9(18):1401. PubMed ID: 34733953 [TBL] [Abstract][Full Text] [Related]
11. Identification and Analysis of Hub Genes in Diabetic Cardiomyopathy: Potential Role of Cytochrome P450 1A1 in Mitochondrial Metabolism and STZ-Induced Myocardial Dysfunction. Chen Y; Yang J; Wang Y; Shen W; Liu J; Yuan M; Hao X; Zhong L; Guo R Front Cardiovasc Med; 2022; 9():835244. PubMed ID: 35387435 [TBL] [Abstract][Full Text] [Related]
12. Identification of Signature Genes of Dilated Cardiomyopathy Using Integrated Bioinformatics Analysis. Wu Z; Wang X; Liang H; Liu F; Li Y; Zhang H; Wang C; Wang Q Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108502 [TBL] [Abstract][Full Text] [Related]
13. Exploring the Role of Obesity in Dilated Cardiomyopathy Based on Bio-informatics Analysis. Wang X; Liu W; Li H; Ding J; Feng Y; Chen Z J Cardiovasc Dev Dis; 2022 Dec; 9(12):. PubMed ID: 36547458 [TBL] [Abstract][Full Text] [Related]
14. Machine learning and bioinformatics to identify 8 autophagy-related biomarkers and construct gene regulatory networks in dilated cardiomyopathy. Zhang F; Xia M; Jiang J; Wang S; Zhao Q; Yu C; Yu J; Xian D; Li X; Zhang L; Liu Y; Peng M Sci Rep; 2022 Sep; 12(1):15030. PubMed ID: 36056063 [TBL] [Abstract][Full Text] [Related]
15. Identification of Potential Biomarkers Associated with Dilated Cardiomyopathy by Weighted Gene Coexpression Network Analysis. Guo Q; Qu Q; Wang L; Liao S; Zhu X; Du A; Zhu Q; Cheang I; Gao R; Li X Front Biosci (Landmark Ed); 2022 Aug; 27(8):246. PubMed ID: 36042172 [TBL] [Abstract][Full Text] [Related]
16. Integrated Bioinformatics Algorithms and Experimental Validation to Explore Robust Biomarkers and Landscape of Immune Cell Infiltration in Dilated Cardiomyopathy. Zhang Q; Fan M; Cao X; Geng H; Su Y; Wu C; Pan H; Pan M Front Cardiovasc Med; 2022; 9():809470. PubMed ID: 35433865 [TBL] [Abstract][Full Text] [Related]
17. Identification of differentially expressed long non-coding RNAs associated with dilated cardiomyopathy using integrated bioinformatics approaches. Luo X; Luo P; Zhang Y Drug Discov Ther; 2020 Sep; 14(4):181-186. PubMed ID: 32727980 [TBL] [Abstract][Full Text] [Related]
18. Identification of senescence related hub genes and potential therapeutic compounds for dilated cardiomyopathy via comprehensive transcriptome analysis. Du C; Wang S; Shi X; Jing P; Wang H; Wang L Comput Biol Med; 2024 Sep; 179():108901. PubMed ID: 39029429 [TBL] [Abstract][Full Text] [Related]
19. Integrative bioinformatics analysis of potential therapeutic targets and immune infiltration characteristics in dilated cardiomyopathy. Yang Y; Liu P; Teng R; Liu F; Zhang C; Lu X; Ding Y Ann Transl Med; 2022 Mar; 10(6):348. PubMed ID: 35433958 [TBL] [Abstract][Full Text] [Related]
20. Identification and Validation of Dilated Cardiomyopathy-Related Genes via Bioinformatics Analysis. Wang LJ; Qiu BQ; Yuan MM; Zou HX; Gong CW; Huang H; Lai SQ; Liu JC Int J Gen Med; 2022; 15():3663-3676. PubMed ID: 35411175 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]